14th May 2020 07:00
Silence Therapeutics to Participate in Fireside Chat at the RBC Capital Markets Global Healthcare Virtual Conference
14 May 2020
LONDON, Silence Therapeutics plc (LON: SLN) ("Silence" or "the Company"), a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious diseases, today announces that Dr. Rob Quinn, Chief Financial Officer, will be participating in a fireside chat at the 2020 RBC Capital Markets Global Healthcare Virtual Conference.
Date: | Wednesday, May 20, 2020 | |
Time: | 10:55 am EDT (15:55 BST) | |
Webcast link: | Silence Therapeutics fireside chat |
A live webcast of the event can be accessed via the Investors section of the Company's website at
www.silence-therapeutics.com. An archived replay of the webcast will be available for 60 days on the Company's website after the conference.
For more information, please contact:
Silence Therapeutics plc Iain Ross, Executive Chairman Rob Quinn, Chief Financial Officer
| Tel: +44 (0)20 3457 6900 |
Peel Hunt LLP (Nominated Adviser and Broker) James Steel/Oliver Jackson
| Tel: +44 (0)20 7418 8900 |
European IR Consilium Strategic Communications Mary-Jane Elliott/Chris Welsh/Angela Gray
| Tel: +44 (0) 20 3709 5700 |
U.S. IR Westwicke Peter Vozzo | Tel: +1 (443) 213-0505 |
About Silence Therapeutics plc
Silence Therapeutics is developing a new generation of medicines by harnessing the body's natural mechanism of RNA interference, or RNAi, within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-associated proteins. Silence's proprietary RNA chemistries and delivery systems are designed to improve the stability of molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life-threatening diseases. The Company has secured high value research and collaboration agreements with AstraZeneca, Mallinckrodt Pharmaceuticals and Takeda. For more information, please visit: https://www.silence-therapeutics.com/
Related Shares:
SLN.L